Camps Manel, Naukkarinen Jussi, Johnson Ben P, Loeb Lawrence A
The Joseph Gottstein Memorial Cancer Research Laboratory, Department of Pathology, University of Washington, Seattle, WA 98195-7705, USA.
Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9727-32. doi: 10.1073/pnas.1333928100. Epub 2003 Aug 8.
We present a system for random mutagenesis in Escherichia coli for the evolution of targeted genes. To increase error rates of DNA polymerase I (Pol I) replication, we introduced point mutations in three structural domains that govern Pol I fidelity. Expression of error-prone Pol I in vivo results in strong mutagenesis of a target sequence encoded in a Pol I-dependent plasmid (8.1 x 10-4 mutations per bp, an 80,000-fold increase), with a preference for plasmid relative to chromosome sequence. Mutagenesis is maximal in cultures maintained at stationary phase. Mutations are evenly distributed and show a variety of base pair substitutions, predominantly transitions. Mutagenesis extends at least 3 kb beyond the 400-500 nt reportedly synthesized by Pol I. We demonstrate that our error-prone Pol I can be used to generate enzymes with distinct properties by generating TEM-1 beta-lactamase mutants able to hydrolyze a third-generation lactam antibiotic, aztreonam. Three different mutations contribute to aztreonam resistance. Two are found in the extended-spectrum beta-lactamases most frequently identified in clinical isolates, and the third (G276R) has not been previously described. Our system of targeted mutagenesis in E. coli should have an impact on enzyme-based applications in areas such as synthetic chemistry, gene therapy, and molecular biology. Given the structural conservation between polymerases, this work should also provide a reference for altering the fidelity of other polymerases.
我们提出了一种用于大肠杆菌中随机诱变以实现靶向基因进化的系统。为了提高DNA聚合酶I(Pol I)复制的错误率,我们在控制Pol I保真度的三个结构域中引入了点突变。体内易出错的Pol I的表达导致Pol I依赖性质粒中编码的靶序列发生强烈诱变(每碱基对8.1×10⁻⁴个突变,增加了80000倍),相对于染色体序列,更倾向于质粒。在稳定期培养的培养物中诱变作用最大。突变均匀分布,呈现出各种碱基对替换,主要是转换。诱变作用延伸至据报道由Pol I合成的400 - 500 nt之外至少3 kb处。我们证明,通过产生能够水解第三代内酰胺抗生素氨曲南的TEM - 1β-内酰胺酶突变体,我们的易出错的Pol I可用于生成具有不同特性的酶。三种不同的突变导致了对氨曲南的抗性。其中两种存在于临床分离株中最常见的超广谱β-内酰胺酶中,第三种(G276R)此前尚未有描述。我们在大肠杆菌中的靶向诱变系统应该会对合成化学、基因治疗和分子生物学等领域基于酶的应用产生影响。鉴于聚合酶之间的结构保守性,这项工作也应该为改变其他聚合酶的保真度提供参考。